← All peptidesPDA-V1 attestation Citations
verifiedBioGate · GREENGrade B
Thymosin α1 (Zadaxin)
SDAAVDTSSEITTKDLKEKKEVVEEAEN28-residue immunomodulatory peptide; promotes T-cell maturation via TLR signaling. Approved in 35+ countries (not FDA) for hepatitis indications.
acetylated N-terminus
MW
3108.31
Length
28aa
Posterior
32.0%
Structural preview · ESMFold-2 mockdeterministic per sequence
Backbone preview · acetylated N-terminus
Cryptographic chain of custody.
- Outer PDA hash
- Inputs hash
- Merkle root
- TEE attestation
- Protocol version
- PDA-V1
- Source
- peptide-md
- Model version
- structure-fm-2026.04
- Candidates emitted
- 3
- Signed
- 2026-04-21T08:14:33Z
Verifiable in your browser at /verifier with
@peptide-md/verifier.Real-world evidence
Cohort-attested outcomes.
Cohorts
5
Participants
516
Mean Δ
-0.62
Δ HRV ms (8-week) · 95% CI [-2.29, 1.06]
IPNFT - Not minted
This peptide is not currently represented as an IPNFT. Cohort outcomes feed back into the unminted pool.
Source literature.
Grade B2007 · Curr Opin Pharmacol
Thymosin alpha 1: a historical overview
Garaci E et al.